Understanding Competition in U.S. Prescription Drug Markets: Entry and Supply Chain Dynamics #00486

Submission Number:
00486
Commenter:
Colin Valenta
State:
New York
Initiative Name:
Understanding Competition in U.S. Prescription Drug Markets: Entry and Supply Chain Dynamics
I own two pharmacies and see first hand the negative impact of consolidating networks and lack of oversite over pharmacy benefit managers (PBMs) on my patients. Plase do not allow the CVS/Aetna merger. Also please do anything you can to promote transparency and oversite in the PBM industry which is essentially completely unregulated. Thank you.